Off-label use of medication may be presented in these guidelines if a sufficient level of
evidence shows that it can be considered medically appropriate to a given condition and if …

Tricuspid Regurgitation | NEJM Skip to main content NEJM Group Follow Us Facebook Twitter
Instagram YouTube LinkedIn Prepare to become a physician, build your knowledge, lead a …

ESC Guidelines e341 (1) the specific situation of the patient. In this respect, it is specified
that, unless otherwise provided for by national regulations, offlabel use of medication should …

Background Pulmonary arterial hypertension is a progressive disease involving proliferative
remodeling of the pulmonary vessels. Despite therapeutic advances, the disease-associated …

Right Ventricular Failure | NEJM Skip to main content NEJM Group Follow Us Facebook Twitter
Instagram YouTube LinkedIn Prepare to become a physician, build your knowledge, lead a …

Pulmonary hypertension, defined as an elevation in blood pressure in the pulmonary
arteries, is associated with an increased risk of death. The prevalence of pulmonary …

Since the 2009 publication of the stress echocardiography expert consensus of the
European Association of Echocardiography, and after the 2016 advice of the American …

Since the last World Symposium on Pulmonary Hypertension in 2008, we have witnessed
numerous and exciting developments in chronic thromboembolic pulmonary hypertension …

Pulmonary hypertension (PH) is an uncommon yet severe condition characterized by
sustained elevation of blood pressure in the pulmonary arteries. The delaying treatment can …

The pulmonary vasculature has been frequently overlooked in acute and chronic lung
diseases, such as acute respiratory distress syndrome (ARDS), pulmonary fibrosis (PF), and …